Results 201 to 210 of about 1,151,634 (240)
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Editorial: Diagnostic and treatment strategies for periodontal disease. [PDF]
Janakiram C +3 more
europepmc +1 more source
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte +13 more
wiley +1 more source
Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks? [PDF]
Irwin DJ.
europepmc +1 more source
Genetic insights of sleep apnea symptomatology and endotypes. [PDF]
Ollila HM.
europepmc +1 more source
Advances in Microbial Diagnostics: Machine Learning and Nanotechnology for Zoonotic Disease Control. [PDF]
Lotfalizadeh N +8 more
europepmc +1 more source
EndoCompass Project: Endocrine Laboratory Medicine.
Heijboer AC +9 more
europepmc +1 more source

